Concepedia

Junchen Gu

JG

Statistics

Publications

14

Citations

2.1K

H-Index

13

Active since

2010

Affiliations

Janssen (United States)(Current)

Janssen (Belgium)

Washington University in St. Louis

University of California, San Francisco

Bristol-Myers Squibb (Germany)

Junchen Gu is an author at Janssen (United States) specializing in medicine, oncology, and epigenomics.

Publications per year

2010–2024

14

Publications

14

Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications

R. Alan Harris, Ting Wang, Cristian Coarfa et al. · Nature Biotechnology · 2010 · 739 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial

R. Wendel Naumann, Antoine Hollebecque, Tim Meyer et al. · Journal of Clinical Oncology · 2019 · 435 citations

Medicine, Oncology, Pharmacotherapy +17

Neoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 Trial

Suzanne L. Topalian, Shailender Bhatia, Asim Amin et al. · Journal of Clinical Oncology · 2020 · 271 citations · Full text

Medicine, Immunology, Oncology +17

Functional DNA methylation differences between tissues, cell types, and across individuals discovered using the M&M algorithm

Bo Zhang, Yan Zhou, Nan Lin et al. · Genome Research · 2013 · 203 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

CAR+ T-Cell Lymphoma Post Ciltacabtagene Autoleucel Therapy for Relapsed Refractory Multiple Myeloma

Simon J. Harrison, Tamia Nguyen, Marzia Rahman et al. · Blood · 2023 · 97 citations

Medicine, Hematology, Oncology +12

1–5 of 14